Home > PJ (current issue) > Broad Spectrum | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7422 p446
14 October 2006

This article
Reprint   Photocopy

PDF 30K, Acrobat Reader

Comment

Examining the Society's dual role through sociological spectacles

By Malcolm E. Brown

Malcolm E. Brown is a pharmacist and sociologist from Beccles, Suffolk

Events are occurring within the pharmacy world that threaten to reshape our landscape. The upheaval is that our Royal Pharmaceutical Society seems likely to have to lose its regulatory or leadership functions.

Like most other members, I wanted our Society to continue to exercise both functions as it has done for generations. To be part of the generation that lost that dual role would feel like a disgrace. An analogy is the aristocrat who, after decades of punitive taxation, finally forced to relinquish the family seat.

But that is nostalgia — the comfortable memory of a past that sometimes seems more golden that it actually was. Public distrust in the motives of the professions is part of the reduced respect for authority that has grown in western societies since the 1960s. High profile cases such as Shipman have escalated the change. Today the public demand regulators that are seen to be only concerned with the public interest; a regulator that also represents the interests of the profession — such as our Society — will probably no longer do.

Our Society strives to be a “people pleaser”, the people being both patients and the members of the profession. This article examines that dual role through particular sociological spectacles as a contribution to the debate.

On the one hand, regulation of a profession by a completely impartial organisation, that only possesses interests outside itself — specifically the good of patients — can be seen to have just one reason. That is altruism. Max Weber, founding father of sociology, said that altruism was one of the main reasons for human behaviour. An example of an altruistic institution is a charity; Society members recently rejected mooted charitable status.

On the other hand, a membership body that is a professional leader, by enhancing standards, should improve the status of its members. That is often associated with enhanced material circumstances or class position. It is likely to follow even if, like our Society, the institution is forbidden to participate in any trade union activity. That reason is instrumentality, egotism or self-interest. Weber identified instrumentality as another reason for human behaviour.

Bisected so simplistically, the status quo of our Society’s dual role probably seems unsustainable. I regret that.

In practice, its dual roles are entangled. Our Society has achieved both altruistic and instrumental objectives, each increasing the other in a “positively synergistic spiral” (or “feedback”, like the resulting sound from a microphone and loudspeaker that are too close together). For example, practitioners who kept patient details confidential (altruism) were more highly regarded by patients. The patients would trust those practitioners and so would tend to return for more healing — and pay (instrumentality).

Somehow our Society has, over generations, fulfilled both purposes: a dazzling performance. This cannot have been comfortable and our history is littered with torment. Recent examples are the closure of Birdsgrove House and the “Save Our Society” group that stimulated revision of our Royal Charter. But generally our Society has appeared comparatively calm while being torn by the tensions of dual altruistic and instrumental motivations. The person who claims to feel at a comfortable average temperature with one foot in freezing water and the other foot in boiling water comes to mind.

Yet for me, an ordinary member, it has felt reasonably relaxed. It has been “home”. I have felt proud to be a member, proud of our long history of professional self-improvement, proud that the Society bothered to percolate pharmacy into every cranny of my career. I have enjoyed meeting like-minded people. The existence of a benevolent fund has reassured me. Members receiving snotty disciplinary letters feel bad but want to conform co-operatively because they believe that another part of their Society cares about them. Indeed, there is the “Listening Friend” scheme. Members suspect that, if a microphone were accidentally left on deep within the secret bowels of the organisation, a luminary would seldom be overheard to broadcast, “Yo, members!”

Perhaps during pharmacists’ professionalisation endeavour, our Society was an essential intermediate step. By looking after patients and members it allowed members to develop their sense of altruistic commitment to patients so it became a passion. Altruism to patients may have been a consequence of our Society that its founding fathers did not intend. But each generation has stood upon the shoulders of the generation before and the youngsters’ sincere belief in altruistic reasons for pharmacists’ existence has grown.

Altruism is now so well accepted that members may countenance the creation of a completely impartial regulatory body — a governmental “General Pharmaceutical Council” or equivalent that has zero concern about the interests of pharmacists.

If that were to be the case, our Society would have created its offspring even if during the process of giving birth, our Society as we know it, dies. But it would not be a death but a rebirth.

Let us look on the plus side. Presumably, pharmacists would pay less or nothing for such regulation; the public should pay some of the overheads out of taxes. Certainly registrants should pay less because the institution would be doing less. There probably would be no need for information services, a museum, district, regional or national branch structures and, if a journal were required, it would have little to address.

Pharmacists could enjoy letters that were more succinct and, arguably, more understandable to the public. Presently “MRPharmS” or “FRPharmS” defines an individual as a pharmacist; a possible replacement is “RPh”, an abbreviation for state-registered pharmacist.

There are opportunities for the professional leadership role and promoting the aspiration towards excellence. Institutions may dissolve and reform.

The College of Pharmacy Practice (CPP) is one contender. Our Society planted the CPP’s seeds a generation ago. Probably, if our present Society injected funds, increased membership, intellectual capital and achievement, the development of the CPP, a charity, would be brisk. For example, the title “The Royal College of Pharmacy Practice” may rapidly follow. Farewell M(F)RPharmS. Greetings M(F)RCPP.

Then there is the trade union-type function. Perhaps the National Pharmacy Association and Guild of Healthcare Pharmacists would not receive funds from our “dissolved” Society because it was forbidden trade union activity. What is needed is an utterly instrumental union for employee community pharmacists — union clout might enhance salaries towards more professional levels.

On balance, exciting opportunities exist.

Back to Top


©The Pharmaceutical Journal